Companion Diagnostics Market Size, Share & Trends Analysis Report By product And service, By Indication, By Technology, By Sample Type, By End-use, By Region, And Segment Forecasts, 2026

The global companion diagnostics market size was estimated at USD 9.56 billion in 2025 and is projected to reach USD 20.05 billion by 2033, growing at a CAGR of 10.07% from 2026 to 2033. Growth is supported by increasing demand for precision medicine and the rising prevalence of cancer, cardiovascular diseases, and autoimmune disorders, which are contributing to the need for targeted therapies.

The transition from a one-size-fits-all treatment approach to personalized medicine continues to support the expansion of the companion diagnostics market. In addition, pharmaceutical companies are increasingly integrating companion diagnostics into drug development pipelines to improve the success rate of novel therapeutics, further contributing to the growth of the companion diagnostics industry.

Rapid advancements in diagnostic technologies are supporting the expansion of the companion diagnostics industry. Innovations in next-generation sequencing (NGS), polymerase chain reaction (PCR), and digital pathology have improved the accuracy and efficiency of biomarker identification. These technologies enable faster and more precise detection of genetic mutations and protein expression, which are essential for personalized treatment decisions. In addition, artificial intelligence (AI) and machine learning (ML) are enhancing diagnostic accuracy and data interpretation, supporting more informed clinical decision-making. The growing adoption of these advanced diagnostic tools across research laboratories and healthcare institutions is contributing to market growth, as providers increasingly focus on delivering precise and data-driven patient care.

Regulatory support and favorable reimbursement policies are also contributing to the market growth. Government agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have established clear regulatory pathways to facilitate the approval of companion diagnostic tests alongside targeted therapies. The increasing number of FDA-approved companion diagnostics is indicative of the growing acceptance of personalized medicine. For instance, in October 2024, Roche announced that its VENTANA Assay had become the first immunohistochemistry (IHC) companion diagnostic approved by the U.S. Food and Drug Administration (FDA) for assessing CLDN18 protein expression in tumors of patients with gastric or gastroesophageal junction adenocarcinoma. This approval enables eligible patients to receive treatment with Astellas' targeted therapy, VYLOY. Additionally, reimbursement policies are evolving to accommodate the cost of these advanced diagnostics, making them more accessible to patients. As regulatory bodies continue to support the co-development of drugs and diagnostics, pharmaceutical and biotech companies are investing heavily in developing new companion diagnostic tests to enhance treatment precision and market penetration.

The rising prevalence of oncology-related diseases is another significant factor driving the growth of the companion diagnostics industry. Cancer remains one of the leading causes of death worldwide, and companion diagnostics play a vital role in oncology treatment by identifying genetic mutations that guide the selection of targeted therapies. Cancer remains a significant health challenge and a leading cause of mortality in the 21st century. According to a study published in The Lancet in September 2025, findings from the Global Burden of Disease (GBD) 2023 study indicate that cancer burden was assessed across 47 cancer types in 204 countries and territories from 1990 to 2023, with projections extending to 2050. Cancer was estimated to be the second leading cause of death globally in 2023, following cardiovascular diseases, with total cancer-related deaths projected to exceed 18 million by 2050.

Companies such as Roche Diagnostics, Thermo Fisher Scientific, and Qiagen are actively investing in companion diagnostics for various cancer types, including lung, breast, and colorectal cancer. The increasing incidence of these cancers has driven a greater demand for early and accurate diagnosis, prompting healthcare providers to integrate companion diagnostics into routine clinical practice. As precision oncology continues to gain traction, the market for companion diagnostics is expected to expand further, driven by the need for better treatment outcomes and reduced healthcare costs.

Global Companion Diagnostics Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global companion diagnostics market report based on product & service, indication, technology, sample type, end use, and region:

Product and Service Outlook (Revenue, USD Million, 2021 - 2033)
Assays, Kits, & Reagents
Instruments and Systems
Software and Services
Indication Outlook (Revenue, USD Million, 2021 - 2033)
Oncology
Infectious Diseases
Cardiovascular Diseases
Neurological Disorders
Other Indications
Technology Outlook (Revenue, USD Million, 2021 - 2033)
Polymerase Chain Reaction (PCR)
Next-generation Sequencing (NGS)
In-situ Hybridization (ISH)
Immunohistochemistry (IHC)
Magnetic Resonance Imaging (MRI)
Other Technology
Sample Type Outlook (Revenue, USD Million, 2021 - 2033)
Tissue Samples
Blood Samples
Other Sample Types
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Academic & Research Centers
Hospitals & Physician Laboratories
CROs
Reference Laboratories
Pharmaceutical & Biotechnology Companies
Other End-use
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Thailand
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Product Code: GVR-4-68040-536-9

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Companion Diagnostics Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Companion Diagnostics Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape
- 3.4.3. Pipeline
- 3.4.4. Case Study

Chapter 4. Companion Diagnostics Market: Product and Service Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Companion Diagnostics Market: Product and Service Movement Analysis, 2025 & 2033 (USD Million)
4.3. Assays, Kits, and Reagents
- 4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4. Instruments and Systems
- 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Software and Services
- 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Companion Diagnostics Market: Indication Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Companion Diagnostics Market: Indication Movement Analysis, 2025 & 2033 (USD Million)
5.3. Oncology
- 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4. Infectious Diseases
- 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Cardiovascular Diseases
- 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Neurological Disorders
- 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Other Indications
- 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Companion Diagnostics Market: Technology Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Companion Diagnostics Market: Sample Type Movement Analysis, 2025 & 2033 (USD Million)
6.3. Polymerase Chain Reaction (PCR)
- 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Next-generation Sequencing (NGS)
- 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. In-situ Hybridization (ISH)
- 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Immunohistochemistry (IHC)
- 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Magnetic Resonance Imaging (MRI)
- 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Other Technology
- 6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Companion Diagnostics Market: Sample Type Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Companion Diagnostics Market: Sample Type Movement Analysis, 2025 & 2033 (USD Million)
7.3. Tissue Samples
- 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4. Blood Samples
- 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Other Sample Types
- 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Companion Diagnostics Market: End Use Estimates & Trend Analysis

8.1. Segment Dashboard
8.2. Companion Diagnostics Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
8.3. Academic and Research Centers
- 8.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4. Hospitals and Physician Laboratories
- 8.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. CROs
- 8.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Reference Laboratories
- 8.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7. Pharmaceutical and Biotechnology Companies
- 8.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8. Other End-use
- 8.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Companion Diagnostics Market: Regional Estimates & Trend Analysis

9.1. Companion Diagnostics Market Share, By Region, 2025 & 2033 (USD Million)
9.2. North America
- 9.2.1. North America Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.2.2. U.S.
  - 9.2.2.1. U.S. Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.2.3. Canada
  - 9.2.3.1. Canada Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.2.4. Mexico
  - 9.2.4.1. Mexico Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3. Europe
- 9.3.1. Europe Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.3.2. UK
  - 9.3.2.1. UK Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.3.3. Germany
  - 9.3.3.1. Germany Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.3.4. France
  - 9.3.4.1. France Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.3.5. Italy
  - 9.3.5.1. Italy Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.3.6. Spain
  - 9.3.6.1. Spain Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.3.7. Denmark
  - 9.3.7.1. Denmark Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.3.8. Sweden
  - 9.3.8.1. Sweden Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.3.9. Norway
  - 9.3.9.1. Norway Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4. Asia Pacific
- 9.4.1. Asia Pacific Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.2. Japan
  - 9.4.2.1. Japan Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.3. China
  - 9.4.3.1. China Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.4. India
  - 9.4.4.1. India Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.5. Australia
  - 9.4.5.1. Australia Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.6. South Korea
  - 9.4.6.1. South Korea Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.7. Thailand
  - 9.4.7.1. Thailand Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5. Latin America
- 9.5.1. Latin America Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.2. Brazil
  - 9.5.2.1. Brazil Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.3. Argentina
  - 9.5.3.1. Argentina Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6. Middle East and Africa
- 9.6.1. Middle East and Africa Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.2. South Africa
  - 9.6.2.1. South Africa Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.3. Saudi Arabia
  - 9.6.3.1. South Africa Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.4. UAE
  - 9.6.4.1. UAE Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.5. Kuwait
  - 9.6.5.1. Kuwait Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Company Heat Map Analysis
10.4. Company Profiles
- 10.4.1. QIAGEN
  - 10.4.1.1. Participant's Overview
  - 10.4.1.2. Financial Performance
  - 10.4.1.3. Product and Service Benchmarking
  - 10.4.1.4. Recent Developments/ Strategic Initiatives
- 10.4.2. Agilent Technologies, Inc.
  - 10.4.2.1. Participant's Overview
  - 10.4.2.2. Financial Performance
  - 10.4.2.3. Product and Service Benchmarking
  - 10.4.2.4. Recent Developments/ Strategic Initiatives
- 10.4.3. Abbott
  - 10.4.3.1. Participant's Overview
  - 10.4.3.2. Financial Performance
  - 10.4.3.3. Product and Service Benchmarking
  - 10.4.3.4. Recent Developments/ Strategic Initiatives
- 10.4.4. Thermo Fisher Scientific, Inc.
  - 10.4.4.1. Participant's Overview
  - 10.4.4.2. Financial Performance
  - 10.4.4.3. Product and Service Benchmarking
  - 10.4.4.4. Recent Developments/ Strategic Initiatives
- 10.4.5. F. Hoffmann La Roche Ltd
  - 10.4.5.1. Participant's Overview
  - 10.4.5.2. Financial Performance
  - 10.4.5.3. Product and Service Benchmarking
  - 10.4.5.4. Recent Developments/ Strategic Initiatives
- 10.4.6. Foundation Medicine
  - 10.4.6.1. Participant's Overview
  - 10.4.6.2. Financial Performance
  - 10.4.6.3. Product and Service Benchmarking
  - 10.4.6.4. Recent Developments/ Strategic Initiatives
- 10.4.7. Myriad Genetics
  - 10.4.7.1. Participant's Overview
  - 10.4.7.2. Financial Performance
  - 10.4.7.3. Product and Service Benchmarking
  - 10.4.7.4. Recent Developments/ Strategic Initiatives
- 10.4.8. Illumina, Inc.
  - 10.4.8.1. Participant's Overview
  - 10.4.8.2. Financial Performance
  - 10.4.8.3. Product and Service Benchmarking
  - 10.4.8.4. Recent Developments/ Strategic Initiatives
- 10.4.9. BioMerieux
  - 10.4.9.1. Participant's Overview
  - 10.4.9.2. Financial Performance
  - 10.4.9.3. Product and Service Benchmarking
  - 10.4.9.4. Recent Developments/ Strategic Initiatives
- 10.4.10. Leica Biosystems
  - 10.4.10.1. Participant's Overview
  - 10.4.10.2. Financial Performance
  - 10.4.10.3. Product and Service Benchmarking
  - 10.4.10.4. Recent Developments/ Strategic Initiatives
- 10.4.11. Guardant Health, Inc.
  - 10.4.11.1. Participant's Overview
  - 10.4.11.2. Financial Performance
  - 10.4.11.3. Product and Service Benchmarking
  - 10.4.11.4. Recent Developments/ Strategic Initiatives
- 10.4.12. EntroGen, Inc.
  - 10.4.12.1. Participant's Overview
  - 10.4.12.2. Financial Performance
  - 10.4.12.3. Product and Service Benchmarking
  - 10.4.12.4. Recent Developments/ Strategic Initiatives

Product Code: GVR-4-68040-536-9

List of Tables

Table 1 List of abbreviations
Table 2 Global companion diagnostics market, by region, 2021 - 2033 (USD Million)
Table 3 Global companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 4 Global companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 5 Global companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 6 Global companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 7 Global companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 8 North America companion diagnostics market, by country, 2021 - 2033 (USD Million)
Table 9 North America companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 10 North America companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 11 North America companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 12 North America companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 13 North America companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 14 U.S. companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 15 U.S. companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 16 U.S. companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 17 U.S. companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 18 U.S. companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 19 Canada companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 20 Canada companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 21 Canada companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 22 Canada companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 23 Canada companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 24 Mexico companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 25 Mexico companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 26 Mexico companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 27 Mexico companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 28 Mexico companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 29 Europe companion diagnostics market, by country, 2021 - 2033 (USD Million)
Table 30 Europe companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 31 Europe companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 32 Europe companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 33 Europe companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 34 Europe companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 35 UK companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 36 UK companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 37 UK companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 38 UK companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 39 UK companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 40 Germany companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 41 Germany companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 42 Germany companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 43 Germany companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 44 Germany companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 45 France companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 46 France companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 47 France companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 48 France companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 49 France companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 50 Italy companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 51 Italy companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 52 Italy companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 53 Italy companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 54 Italy companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 55 Spain companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 56 Spain companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 57 Spain companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 58 Spain companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 59 Spain companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 60 Denmark companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 61 Denmark companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 62 Denmark companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 63 Denmark companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 64 Denmark companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 65 Sweden companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 66 Sweden companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 67 Sweden companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 68 Sweden companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 69 Sweden companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 70 Norway companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 71 Norway companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 72 Norway companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 73 Norway companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 74 Norway companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 75 Asia Pacific companion diagnostics market, by country, 2021 - 2033 (USD Million)
Table 76 Asia Pacific companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 77 Asia Pacific companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 78 Asia Pacific companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 79 Asia Pacific companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 80 Asia Pacific companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 81 Japan companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 82 Japan companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 83 Japan companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 84 Japan companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 85 Japan companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 86 China companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 87 China companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 88 China companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 89 China companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 90 China companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 91 India companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 92 India companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 93 India companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 94 India companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 95 India companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 96 Australia companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 97 Australia companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 98 Australia companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 99 Australia companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 100 Australia companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 101 South Korea companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 102 South Korea companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 103 South Korea companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 104 South Korea companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 105 South Korea companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 106 Thailand companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 107 Thailand companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 108 Thailand companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 109 Thailand companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 110 Thailand companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 111 Latin America companion diagnostics market, by country, 2021 - 2033 (USD Million)
Table 112 Latin America companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 113 Latin America companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 114 Latin America companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 115 Latin America companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 116 Latin America companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 117 Brazil companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 118 Brazil companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 119 Brazil companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 120 Brazil companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 121 Brazil companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 122 Argentina companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 123 Argentina companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 124 Argentina companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 125 Argentina companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 126 Argentina companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 127 MEA companion diagnostics market, by country, 2021 - 2033 (USD Million)
Table 128 MEA companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 129 MEA companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 130 MEA companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 131 MEA companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 132 MEA companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 133 South Africa companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 134 South Africa companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 135 South Africa companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 136 South Africa companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 137 South Africa companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 138 Saudi Arabia companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 139 Saudi Arabia companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 140 Saudi Arabia companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 141 Saudi Arabia companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 142 Saudi Arabia companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 143 UAE companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 144 UAE companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 145 UAE companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 146 UAE companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 147 UAE companion diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 148 Kuwait companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
Table 149 Kuwait companion diagnostics market, by indication, 2021 - 2033 (USD Million)
Table 150 Kuwait companion diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 151 Kuwait companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
Table 152 Kuwait companion diagnostics market, by end use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Companion Diagnostics market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modeling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter's five forces analysis
Fig. 18 PESTEL analysis
Fig. 19 Companion Diagnostics market: Product and Service outlook key takeaways
Fig. 20 Companion Diagnostics market: Product and Service movement analysis
Fig. 21 Assays, kits, and reagents market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 22 Instruments and systems market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 23 Software and services market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 Companion Diagnostics market: Indication outlook key takeaways
Fig. 25 Companion Diagnostics market: Indication movement analysis
Fig. 26 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 Infectious diseases market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Cardiovascular diseases market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 Neurological disorders market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Other Indications market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 31 Companion Diagnostics market: Technology outlook key takeaways
Fig. 32 Companion Diagnostics market: Technology movement analysis
Fig. 33 Polymerase Chain Reaction (PCR) market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Next-generation Sequencing (NGS) market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 In-situ Hybridization (ISH) market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 Immunohistochemistry (IHC) market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 37 Magnetic Resonance Imaging (MRI) market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 38 Other technology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 39 Companion Diagnostics market: Sample Type outlook key takeaways
Fig. 40 Companion Diagnostics market: Sample Type movement analysis
Fig. 41 Tissue samples market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 42 Blood samples market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Other sample types market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 44 Companion Diagnostics market: End-use outlook key takeaways
Fig. 45 Companion Diagnostics market: End-use movement analysis
Fig. 46 Academic and Research Centers
Fig. 47 Hospitals and Physician Laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 48 CROs market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 49 Reference Laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 50 Pharmaceutical and Biotechnology Companies market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 51 Other End-use market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 52 Regional marketplace outlook, 2025 & 2033 (USD million)
Fig. 53 Regional marketplace: Key takeaways
Fig. 54 North America companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 U.S. companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Canada companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Mexico companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 61 Europe companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 UK companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Germany companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 France companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Spain companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Italy companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Denmark companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Sweden companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Norway companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 78 Asia Pacific companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Japan companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 China companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 India companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Australia companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 South Korea companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Thailand companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 91 Latin America companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 Brazil companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 Argentina companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 96 Middle East & Africa companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 97 Key country dynamics
Fig. 98 South Africa companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 99 Key country dynamics
Fig. 100 Saudi Arabia companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 101 Key country dynamics
Fig. 102 UAE companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 103 Key country dynamics
Fig. 104 Kuwait companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 105 Market participant categorization
Fig. 106 Companion Diagnostics market position analysis, 2025
Fig. 107 Strategic framework

Companion Diagnostics Market Size, Share & Trends Analysis Report By product And service, By Indication, By Technology, By Sample Type, By End-use, By Region, And Segment Forecasts, 2026 - 2033

Description

Table of Contents

List of Tables

Companion Diagnostics Market Summary

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Companion Diagnostics Market Variables, Trends, & Scope

Chapter 4. Companion Diagnostics Market: Product and Service Estimates & Trend Analysis

Chapter 5. Companion Diagnostics Market: Indication Estimates & Trend Analysis

Chapter 6. Companion Diagnostics Market: Technology Estimates & Trend Analysis

Chapter 7. Companion Diagnostics Market: Sample Type Estimates & Trend Analysis

Chapter 8. Companion Diagnostics Market: End Use Estimates & Trend Analysis

Chapter 9. Companion Diagnostics Market: Regional Estimates & Trend Analysis

Chapter 10. Competitive Landscape

List of Tables

List of Figures